Type 1 helper T cell (Th1) (Th1)

Type 1 helper T (Th1) cells are a specialized lineage of CD4+ effector T lymphocytes essential for host defense against intracellular pathogens (StatPearls, NBK541030). They are characterized by the production of interferon-gamma (IFN-γ), which activates macrophages and promotes cell-mediated immunity (Nature Reviews Immunology, 2006). The differentiation of Th1 cells is primarily driven by interleukin-12 (IL-12) and the master transcription factor T-bet (UniProt, Q9JKD8). These cells play a critical role in the elimination of viruses and bacteria that reside within host cells. While vital for clearing infections, excessive or dysregulated Th1 activity is a hallmark of several autoimmune and inflammatory disorders, such as Crohn's disease and rheumatoid arthritis (PubMed, 11911823). In these conditions, Th1-mediated inflammation leads to tissue damage and chronic disease progression. Therapeutic strategies targeting Th1 cells include the use of monoclonal antibodies like ustekinumab, which inhibits the IL-12 signaling required for Th1 development (NCBI, PMC3135093). Other approaches involve neutralizing Th1-derived cytokines or using broad immunosuppressants to reduce T-cell activation. Conversely, in oncology, enhancing Th1 responses is a goal of certain immunotherapies to improve anti-tumor immunity.

Other names

T helper 1 cellTh1 lymphocyteCD4+ Th1 cellType 1 T-helper cell

Inhibition of Th1 differentiation via IL-12/IL-23 antagonism, neutralization of Th1-secreted cytokines such as IFN-gamma and TNF-alpha, or broad suppression of T-cell receptor signaling and proliferation.